Ionis Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Ionis Pharmaceuticals patents 237 in total
| Status | Patent |
|---|---|
Application | Utility: COMPOSITIONS FOR MODULATING C9ORF72 EXPRESSION Filling date: 8 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATION OF PROTEIN AGGREGATION Filling date: 8 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: MORPHOLINO MODIFIED OLIGOMERIC COMPOUNDS Filling date: 8 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING HBV EXPRESSION Filling date: 8 Sep 2025 Issue date: 16 Jul 2020 |
Application | Utility: Antisense Compounds and Uses Thereof Filling date: 8 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: MODULATORS OF IRF5 EXPRESSION Filling date: 8 Sep 2025 Issue date: 2 Jul 2020 |
Application | Utility: Modulators of PCSK9 Expression Filling date: 8 Sep 2025 Issue date: 25 Jun 2020 |
Grant | Utility: Antisense modulation of PTP1B expression Filling date: 8 Sep 2025 Issue date: 23 Jun 2020 |
Application | Utility: COMPOUNDS AND METHODS FOR MODULATING TMPRSS6 EXPRESSION Filling date: 8 Sep 2025 Issue date: 18 Jun 2020 |
Application | Utility: MODULATION OF HEPATITIS B VIRUS (HBV) EXPRESSION Filling date: 8 Sep 2025 Issue date: 18 Jun 2020 |
Grant | Utility: Compositions and methods for modulating TTR expression Filling date: 8 Sep 2025 Issue date: 16 Jun 2020 |
Application | Utility: MODULATORS OF FOXP3 EXPRESSION Filling date: 8 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: MODULATION OF THE NOTCH SIGNALING PATHWAY FOR TREATMENT OF RESPIRATORY DISORDERS Filling date: 8 Sep 2025 Issue date: 4 Jun 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR MODULATING ALPHA-1-ANTITRYPSIN EXPRESSION Filling date: 8 Sep 2025 Issue date: 21 May 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR ENHANCED INTESTINAL ABSORPTION OF CONJUGATED OLIGOMERIC COMPOUNDS Filling date: 8 Sep 2025 Issue date: 21 May 2020 |
Grant | Utility: Compositions and their uses directed to huntingtin Filling date: 8 Sep 2025 Issue date: 19 May 2020 |
Application | Utility: MODULATORS OF COMPLEMENT FACTOR B Filling date: 8 Sep 2025 Issue date: 14 May 2020 |
Application | Utility: MODULATORS OF PNPLA3 EXPRESSION Filling date: 8 Sep 2025 Issue date: 7 May 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION Filling date: 8 Sep 2025 Issue date: 23 Apr 2020 |
Application | Utility: MODULATION OF ANGIOPOIETIN-LIKE 3 EXPRESSION Filling date: 8 Sep 2025 Issue date: 16 Apr 2020 |
Grant | Utility: Modulation of huntingtin expression Filling date: 8 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Cancer treatment Filling date: 8 Sep 2025 Issue date: 14 Apr 2020 |
Grant | Utility: Method for solution phase detritylation of oligomeric compounds Filling date: 8 Sep 2025 Issue date: 14 Apr 2020 |
Application | Utility: MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPODYSTROPHY POPULATIONS Filling date: 8 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: COMPOSITIONS FOR MODULATING ATAXIN 2 EXPRESSION Filling date: 8 Sep 2025 Issue date: 19 Mar 2020 |
Grant | Utility: Compositions and methods for modulation nucleic acids through nonsense mediated decay Filling date: 8 Sep 2025 Issue date: 17 Mar 2020 |
Application | Utility: Compositions and Methods for Modulating MECP2 Expression Filling date: 8 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: ALLELE SPECIFIC MODULATORS OF P23H RHODOPSIN Filling date: 8 Sep 2025 Issue date: 5 Mar 2020 |
Grant | Utility: Modulation of DYRK1B expression Filling date: 8 Sep 2025 Issue date: 3 Mar 2020 |
Grant | Utility: Methods for monitoring C9ORF72 expression Filling date: 8 Sep 2025 Issue date: 3 Mar 2020 |
Grant | Utility: Conjugated antisense compounds and their use Filling date: 8 Sep 2025 Issue date: 25 Feb 2020 |
Application | Utility: COMPOUNDS AND METHODS FOR REDUCING ATXN2 EXPRESSION Filling date: 8 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: MODULATION OF APOLIPOPROTEIN CIII (APOCIII) EXPRESSION Filling date: 8 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: SELECTIVE ANTISENSE COMPOUNDS AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION Filling date: 8 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATING COMPLEMENT FACTOR B EXPRESSION Filling date: 8 Sep 2025 Issue date: 13 Feb 2020 |
Grant | Utility: Modulating apolipoprotein (a) expression Filling date: 8 Sep 2025 Issue date: 11 Feb 2020 |
Application | Utility: MODULATORS OF DIACYGLYCEROL ACYLTRANSFERASE 2 (DGAT2) Filling date: 8 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR MODULATION OF IKBKAP SPLICING Filling date: 8 Sep 2025 Issue date: 30 Jan 2020 |
Grant | Utility: Compounds and methods for modulation of DUX4 Filling date: 8 Sep 2025 Issue date: 21 Jan 2020 |
Application | Utility: COMPOSITIONS COMPRISING ALTERNATING 2'-MODIFIED NUCLEOSIDES FOR USE IN GENE MODULATION Filling date: 8 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS Filling date: 8 Sep 2025 Issue date: 16 Jan 2020 |
Grant | Utility: Methods for modulating Ataxin 2 expression Filling date: 8 Sep 2025 Issue date: 14 Jan 2020 |
Grant | Utility: Compositions and methods for modulating Ataxin 3 expression Filling date: 8 Sep 2025 Issue date: 14 Jan 2020 |
Grant | Utility: Modulation of nuclear-retained RNA Filling date: 8 Sep 2025 Issue date: 7 Jan 2020 |
Application | Utility: MODULATION OF FACTOR 11 EXPRESSION Filling date: 8 Sep 2025 Issue date: 2 Jan 2020 |
Grant | Utility: Modulators of SMAD7 expression Filling date: 8 Sep 2025 Issue date: 31 Dec 2019 |
Grant | Utility: Modulators of PCSK9 expression Filling date: 8 Sep 2025 Issue date: 31 Dec 2019 |
Application | Utility: ANTISENSE COMPOUNDS TARGETING GENES ASSOCIATED WITH FIBRONECTIN Filling date: 8 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: MODIFIED CRISPR RNA AND USES THEREOF Filling date: 8 Sep 2025 Issue date: 19 Dec 2019 |
Showing 150 to 200 of 237 patents.